China Healthwise Holdings Limited (HKG:0348)

Revenue by Segment

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Chinese Health Products	99.20M	112.83M	129.52M	128.38M	114.20M
Chinese Health Products Growth	-12.08%	-12.89%	0.89%	12.42%	2.17%
Investment in Financial Instruments	-249.00K	-388.00K	6.14M	-945.00K	33.59M
Money Lending Business	613.00K	1.13M	10.66M	14.63M	22.29M
Money Lending Business Growth	-45.80%	-89.39%	-27.15%	-34.38%	-26.40%
Total	99.56M	113.58M	146.32M	142.06M	170.08M
Total Growth	-12.34%	-22.38%	3.00%	-16.48%	23.38%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Hong Kong	99.56M	113.58M	146.32M	141.75M	169.61M
Hong Kong Growth	-12.34%	-22.38%	3.22%	-16.43%	23.04%
The People's Republic of China (The PRC)	-	-	-	308.00K	466.00K
The People's Republic of China (The PRC) Growth	-	-	-	-33.91%	-
Total	99.56M	113.58M	146.32M	142.06M	170.08M
Total Growth	-12.34%	-22.38%	3.00%	-16.48%	23.38%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 17, 2026

Data Sources Report a data error